14-day Premium Trial Subscription Try For FreeTry Free
$14.77
-0.240 (-1.60%)
At Close: Apr 24, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $10.02 $17.49 Wednesday, 24th Apr 2024 CRIS stock ended at $14.77. This is 1.60% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.07% from a day low at $14.71 to a day high of $15.01.
90 days $8.24 $17.49
52 weeks $0.380 $17.49

Historical Curis prices

Date Open High Low Close Volume
Sep 19, 2023 $0.475 $0.479 $0.448 $0.448 287 986
Sep 18, 2023 $0.500 $0.501 $0.469 $0.469 238 029
Sep 15, 2023 $0.500 $0.509 $0.473 $0.488 790 271
Sep 14, 2023 $0.508 $0.521 $0.500 $0.500 355 259
Sep 13, 2023 $0.520 $0.536 $0.509 $0.509 155 242
Sep 12, 2023 $0.538 $0.540 $0.510 $0.512 273 630
Sep 11, 2023 $0.530 $0.556 $0.510 $0.511 186 140
Sep 08, 2023 $0.529 $0.529 $0.500 $0.528 411 096
Sep 07, 2023 $0.526 $0.530 $0.504 $0.528 360 413
Sep 06, 2023 $0.588 $0.588 $0.531 $0.531 177 250
Sep 05, 2023 $0.580 $0.585 $0.551 $0.557 164 578
Sep 01, 2023 $0.560 $0.585 $0.551 $0.579 164 106
Aug 31, 2023 $0.581 $0.581 $0.557 $0.559 334 628
Aug 30, 2023 $0.589 $0.590 $0.571 $0.576 170 853
Aug 29, 2023 $0.570 $0.593 $0.570 $0.592 220 275
Aug 28, 2023 $0.589 $0.600 $0.572 $0.597 88 747
Aug 25, 2023 $0.603 $0.606 $0.584 $0.590 112 372
Aug 24, 2023 $0.600 $0.616 $0.541 $0.613 1 021 642
Aug 23, 2023 $0.578 $0.590 $0.571 $0.585 152 730
Aug 22, 2023 $0.590 $0.599 $0.575 $0.585 284 298
Aug 21, 2023 $0.610 $0.610 $0.580 $0.598 343 296
Aug 18, 2023 $0.627 $0.628 $0.610 $0.618 151 811
Aug 17, 2023 $0.641 $0.665 $0.615 $0.622 233 910
Aug 16, 2023 $0.611 $0.665 $0.601 $0.665 327 573
Aug 15, 2023 $0.630 $0.670 $0.597 $0.618 660 981
Click to get the best stock tips daily for free!

About Curis

Curis Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myeloid leukemia and myelodysplastic syndromes; and CI-8993, a monoclonal antibody designed to antagonize t... CRIS Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 10.86% $52.28
LPLA Apr 19 0.743% $262.59
DOOR Apr 18 0.160% $131.39
LNG Apr 17 0.389% $156.81
FCN Apr 16 2.95% $207.62
ELV Apr 16 5.28% $506.97
DXC Apr 08 0.767% $20.87
AKR Apr 05 5.63% $16.53
ITCI Apr 05 6.84% $68.44
SARK Mar 28 13.80% $26.88
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT